Series D - NeuSpera Medical

Series D - NeuSpera Medical

Investment Firm

Overview

NeuSpera Medical is a manufacturing firm that designs, manufactures, and sells implantable neuromodulation medical devices.

Announced Date

Jul 15, 2024

Closed on Date

Jul 15, 2024

Funding Type

Series D

Highlights

Location

United States, North America

Social

Investor Lead

Treo Ventures

Treo Ventures

Treo Ventures is a early_stage_venture firm.

Participant Investors

4

Investor Name
Participant InvestorOlympus
Participant InvestorWindham Venture Partners
Participant InvestorTreo Ventures
Participant InvestorAction Potential Venture Capital

Round Details and Background

NeuSpera Medical raised $23000000 on 2024-07-15 in Series D

NeuSpera Medical is a manufacturing firm that designs, manufactures, and sells implantable neuromodulation medical devices.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 20, 2021
Series C - NeuSpera Medical
4-65.0M
May 29, 2024
Non Equity Assistance - NeuSpera Medical
1-undefined
Jul 15, 2024
Series D - NeuSpera Medical
5-23.0M
Jun 13, 2016
Venture Round - NeuSpera Medical
-8.9M